CVS Health Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five increased by 4.0% to $11.51B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 9.3%, from $10.53B to $11.51B.
Provides visibility into medium-term cash flow availability from the investment portfolio.
This metric represents the fair value of debt securities in the available-for-sale portfolio maturing between one and fi...
Standard maturity profile disclosure for utilities with structured investment portfolios.
other_available_for_sale_securities_debt_maturities_afte_540252| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.40B | $7.39B | $7.04B | $6.50B | $6.26B | $6.51B | $6.94B | $7.00B | $7.84B | $8.78B | $10.53B | $10.67B | $11.07B | $11.51B |
| QoQ Change | — | -0.1% | -4.8% | -7.6% | -3.7% | +4.0% | +6.6% | +0.8% | +12.0% | +12.1% | +19.9% | +1.3% | +3.7% | +4.0% |
| YoY Change | — | — | — | -12.1% | -15.3% | -7.5% | +6.8% | +11.7% | +20.4% | +26.5% | +50.5% | +36.2% | +26.0% | +9.3% |